Skip to main content
. 2022 Oct 28;14(21):5318. doi: 10.3390/cancers14215318

Table 1.

Immunohistochemical markers used in lymphoma cases of Tokai University, School of Medicine.

Marker Target/Pathway Primary Antibody Company
BCL2 Apoptosis bcl2/100/D5 Novocastra
BCL6 Germinal center LN22 Novocastra
cCASP3 Apoptosis Asp175, #9661 Cell Signaling
CASP8 Apoptosis active subunit p18, 11B6 Novocastra
CD3 T lymphocytes CD3 epsilon, LN10 Novocastra
CD5 T lymphocytes 4C7 Novocastra
CD10 Germinal center 56C6 Novocastra
CD16 M1-like macrophages 2H7 Novocastra
CD20 B lymphocytes L26 Novocastra
CD47 B lymphocytes D3O7P Cell Signaling
CD68 Pan-macrophages 514H12 Novocastra
CD85A/LILRB3 M2-like macrophages FRAS92B CNIO
CD163 M2-like macrophages 10D6 Novocastra
CDK6 Cell cycle 98D CNIO
CSF1 CSF1R pathway 2D10 LSBio
CSF1R M2-like macrophages 2D10 LSBio
Cyclin D1 Cell cycle P2D11F11 Novocastra
E2F1 Cell cycle Agro368V CNIO
EBER Epstein-Barr virus #PB0589, #AR0833 Novocastra
IKAROS Cytokine signaling D6N9Y Cell Signaling
IL10 M2c-like macrophages LS-B7432 Lifespan Bioscience
Ki67 Cell cycle MM1 Novocastra
LMO2 Proto-oncogene 299B CNIO
MARCO Macrophages HPA063793 Atlas antibodies
MDM2 p53 signaling IF2 Invitrogen
MITF M2-like macrophages C5/D5/MAB10775 Abnova
MUM1 Plasma cells IRF4, EAU32 Novocastra
MYC Proto-oncogene Y69 Abcam
NFKB p105/p50 NFKB pathway #3035 Cell Signaling
cPARP Apoptosis Asp214, D64E10 Cell Signaling
PD-L1 Immune checkpoint E1J2J Cell Signaling
p-p44/42 MAPK MAPK pathway Thr202/Tyr204, #4370 Cell Signaling
pSTAT3 STAT3 pathway Tyr705, D3A7 Cell Signaling
PTX3 M2c-like macrophages PPZ1228 Perseus Proteomics
RGS1 Signal transduction Rabbit polyclonal Thermo Fisher
SIRPA M2-like macrophages D6I3M Cell Signaling
TNFAIP8 Apoptosis #14559-MM01 Sino Biological
TP53 Cell cycle, apoptosis DO-7 Novocastra
RGS1 Signal transduction Rabbit polyclonal Thermo Fisher

CNIO, Centro Nacional de Investigaciones Oncológicas (Spanish National Cancer Research Center).